Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations (Unaudited)

v3.8.0.1
Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Sales $ 3,285,000 $ 1,906,000 $ 5,333,037 $ 3,376,600
Cost of Sales 7,558,082 4,173,364 12,866,095 6,932,416
Gross loss (4,273,082) (2,267,364) (7,533,058) (3,555,816)
Operating Expenses        
Selling, general and administrative 3,283,196 1,968,260 8,031,368 4,755,642
Research and development 5,084,419 1,024,470 14,139,074 4,224,208
Total operating expenses 8,367,615 2,992,730 22,170,442 8,979,850
Interest expense, net 26,891 2,765 84,394 43,035
Net loss $ (12,667,588) $ (5,262,859) $ (29,787,894) $ (12,578,701)
Basic and diluted loss per share $ (0.35) $ (0.25) $ (0.83) $ (0.61)
Weighted average number of common shares outstanding 35,930,125 20,665,480 35,930,125 20,665,480